AKNA Human Pre-designed siRNA Set A contains three designed siRNAs for AKNA gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

AKNAD1 Human Pre-designed siRNA Set A contains three designed siRNAs for AKNAD1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

AKR1A1 Human Pre-designed siRNA Set A contains three designed siRNAs for AKR1A1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

AKR1B1 Human Pre-designed siRNA Set A contains three designed siRNAs for AKR1B1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

AKR1B10 Human Pre-designed siRNA Set A contains three designed siRNAs for AKR1B10 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

AKR1C1 Human Pre-designed siRNA Set A contains three designed siRNAs for AKR1C1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

AKR1C2 Human Pre-designed siRNA Set A contains three designed siRNAs for AKR1C2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

AKR1C3 Human Pre-designed siRNA Set A contains three designed siRNAs for AKR1C3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

AKR1C3-IN-11 (Compound 6e) is a Aldo-keto reductase 1C3 (AKR1C3) inhibitor with an IC50 of 2.0 μM. AKR1C3-IN-11 inhibit cell proliferation in combination with abiraterone (HY-70013). AKR1C3-IN-11 can be used for the research of prostate cancer[1].

AKR1C3-IN-12 (compound 2j) is an aldo-keto reductase 1C3 (AKR1C3) inhibitor with an IC50 of 27 nM. AKR1C3-IN-12 enhances the efficacy of Gemcitabine and Cisplatin in bladder cancer[1].

AKR1C4 Human Pre-designed siRNA Set A contains three designed siRNAs for AKR1C4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

AKR1D1 Human Pre-designed siRNA Set A contains three designed siRNAs for AKR1D1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

AKR1E2 Human Pre-designed siRNA Set A contains three designed siRNAs for AKR1E2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

AKR7A2 Human Pre-designed siRNA Set A contains three designed siRNAs for AKR7A2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

AKR7A3 Human Pre-designed siRNA Set A contains three designed siRNAs for AKR7A3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

AKT1 Human Pre-designed siRNA Set A contains three designed siRNAs for AKT1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Akt1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Akt1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Akt1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Akt1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

Akt1-IN-3 (Compd 7) is an inhibitor of AKT1. Akt1-IN-3 inhibits AKT1- E17K with IC50 < 15 nM[1].

Akt1-IN-4 (Compound 62) is an AKT1-E17K inhibitor with an IC50 value of less than 15 nM[1].

AKT1S1 Human Pre-designed siRNA Set A contains three designed siRNAs for AKT1S1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

AKT2 Human Pre-designed siRNA Set A contains three designed siRNAs for AKT2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Akt2 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Akt2 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Akt2 Rat Pre-designed siRNA Set A contains three designed siRNAs for Akt2 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

AKT3 Human Pre-designed siRNA Set A contains three designed siRNAs for AKT3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Akt3 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Akt3 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Akt3 Rat Pre-designed siRNA Set A contains three designed siRNAs for Akt3 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

AKTIP Human Pre-designed siRNA Set A contains three designed siRNAs for AKTIP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

AL 8810 methyl ester is a prostaglandin F(2α) analog and a prostaglandin F(2α) receptor agonist. Can competitively antagonize the effects of the FP receptor agonist Fluprostenol (HY-108560). AL 8810 methyl ester has no significant potency against TP, DP, EP(2), EP(4) receptor subtypes in cell lines[1].

AL-6598 is a partial agonist of the DP and EP prostaglandin receptors. AL-6598 reduces intraocular pressure and is used in glaucoma research[1].

Ala-Ala-Phe-AMC TFA is the TFA salt form for Ala-Ala-Phe-AMC. Ala-Ala-Phe-AMC TFA is a fluorogenic substrate, which is used to for tripeptidyl peptidase II (TPPII) activity determination[1].

ALAD Human Pre-designed siRNA Set A contains three designed siRNAs for ALAD gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ALAS1 Human Pre-designed siRNA Set A contains three designed siRNAs for ALAS1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ALAS2 Human Pre-designed siRNA Set A contains three designed siRNAs for ALAS2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ALB Human Pre-designed siRNA Set A contains three designed siRNAs for ALB gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ALCAM Human Pre-designed siRNA Set A contains three designed siRNAs for ALCAM gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Alclofenac (Allopydin) is a non-steroidal anti-inflammatory agent (NSAID). Alclofenac is a prostaglandin H2 synthase inhibitor. Alclofenac can be used for rheumatoid arthritis, degenerative joint disease and ankylosing spondylitis research[1][1][2].

Aldehyde reactive probe (TFA) is a biotinylated reagent for the detection and quantification of AP sites in damaged DNA[1].

ALDH16A1 Human Pre-designed siRNA Set A contains three designed siRNAs for ALDH16A1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ALDH18A1 Human Pre-designed siRNA Set A contains three designed siRNAs for ALDH18A1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ALDH1A1 Human Pre-designed siRNA Set A contains three designed siRNAs for ALDH1A1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Aldh1a1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Aldh1a1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

ALDH1A1 Rat Pre-designed siRNA Set A contains three designed siRNAs for ALDH1A1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

ALDH1A1-IN-4 (compound A1) is a potent inhibitor of aldehyde dehydrogenase (ALDH) A1, with IC50 value of 0.32 μM. ALDH1A1-IN-4 plays an important role in cancer research[1].